To view the PDF file, sign up for a MySharenet subscription.

ADVTECH LIMITED - Dealings in securities by a prescribed officer of the company

Release Date: 06/06/2024 09:40
Code(s): ADH     PDF:  
Wrap Text
Dealings in securities by a prescribed officer of the company

ADvTECH Limited
(Incorporated in the Republic of South Africa)
(Registration number 1990/001119/06)
Share code: ADH           ISIN: ZAE000031035
("ADvTECH" or "the Company")


DEALINGS IN SECURITIES BY A PRESCRIBED OFFICER OF THE COMPANY


In compliance with the JSE Limited Listings Requirements the following information is disclosed in
respect of dealings in ADvTECH securities by a Prescribed Officer of ADvTECH.


 Name of Prescribed Officer:                       MD Aitken

 Company of which a Prescribed Officer:            ADvTECH Limited

 Type and Class of Securities:                     Ordinary shares

 Nature of transaction:                            On-market sale of shares

 Nature of interest:                               Direct beneficial

 Date of transaction:                              5 June 2024

 Number of securities:                             80 000

 Price per share:                                  R26.25

 Total value of transaction:                       R2 100 000.00

 Clearance to deal:                                Yes




Johannesburg
6 June 2024
Sponsor: Bridge Capital Advisors Proprietary Limited

Date: 06-06-2024 09:40:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story